Financial Statements

Aptose Biosciences Inc.

Aptose Biosciences Inc. (APTO)


Balance Sheet Statement

Download APTO income statement Download APTO income statement
Year 201320142015201620172018
Cash and cash equivalents 0.6519.378.317.9410.6315.30
Short-term investments -11.025.96-0.800.44
Cash and short-term investments 0.6530.3914.277.9411.4315.74
Receivables ------
Inventories ------
Property, Plant & Equipment Net
Goodwill and Intangible Assets ------
Long-term investments ------
Tax assets ------
Total non-current assets --0.53---
Total current assets -
Total assets 1.0330.9015.358.6511.9716.87
Payables 0.710.651.701.320.591.31
Short-term debt ------
Total current liabilities 1.821.931.701.321.762.79
Long-term debt -0.53----
Total debt --0.53---
Deferred revenue ------
Tax Liabilities ------
Deposit Liabilities ------
Total non-current liabilities --0.53---
Total liabilities 1.822.461.701.321.762.79
Other comprehensive income ----4.30-4.32-4.32
Retained earnings (deficit) -199.96-210.51-220.89-235.13-246.77-275.64
Total stockholders equity ------
Investments -11.025.96-0.800.44
Net Debt --0.65-29.86-7.94-11.43-15.74
Other Assets -0.360.490.490.400.75
Other Liabilities 1.101.28--1.181.47

Aptose Biosciences Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Aptose Biosciences Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.